Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021

US$ 3,000.00

Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 SUMMARY Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 provides in depth analysis on Heme Polymerase (EC 2.0.0.0) targeted pipeline...

April 2021 30 pages

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) - Drugs in Development, 2021

US$ 3,000.00

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) - Drugs in Development, 2021 SUMMARY Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) - Drugs in Development,...

April 2021 45 pages

Hemoglobinopathies (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hemoglobinopathies (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hemoglobinopathies (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Hemoglobinopathi...

April 2021 30 pages

Hemophagocytic Lymphohistiocytosis (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hemophagocytic Lymphohistiocytosis (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hemophagocytic Lymphohistiocytosis (Hematological Disorders) - Drugs in Development, 2021 provides an...

April 2021 35 pages

Hemophilia A (Factor VIII Deficiency) (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hemophilia A (Factor VIII Deficiency) (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hemophilia A (Factor VIII Deficiency) (Hematological Disorders) - Drugs in Development, 2021 provid...

April 2021 140 pages

Hemophilia (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hemophilia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hemophilia (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Hemophilia pipeline landscape. T...

April 2021 50 pages

Hemorrhage (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hemorrhage (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hemorrhage (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Hemorrhage pipeline landscape. T...

April 2021 40 pages

Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Hemorrhagic Fever pipeline l...

April 2021 30 pages

Hemorrhagic Shock (Other Diseases) - Drugs in Development, 2021

US$ 2,000.00

Hemorrhagic Shock (Other Diseases) - Drugs in Development, 2021 SUMMARY Hemorrhagic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Hemorrhagic Shock pipeline landscape...

April 2021 45 pages

Hepacivirin (NS3/4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) - Drugs in Development, 2021

US$ 3,000.00

Hepacivirin (NS3/4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) - Drugs in Development, 2021 SUMMARY Hepacivirin (NS3/4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) - Drugs in Developmen...

April 2021 45 pages

Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Hepatic Injury (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Hepatic Injury pipeline landscape. The...

April 2021 50 pages

Hepatic (Liver) Tumor (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Hepatic (Liver) Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Hepatic (Liver) Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Hepatic (Liver) Tumor pipeline landscape...

April 2021 30 pages

Hepatitis B Virus Surface Antigen (HBsAg) - Drugs in Development, 2021

US$ 3,000.00

Hepatitis B Virus Surface Antigen (HBsAg) - Drugs in Development, 2021 SUMMARY Hepatitis B Virus Surface Antigen (HBsAg) - Drugs in Development, 2021 provides in depth analysis on Hepatitis B Virus Su...

April 2021 75 pages

Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021

US$ 3,000.00

Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021 SUMMARY Hepatitis C Virus Envelope Protein E1 - Drugs in Development, 2021 provides in depth analysis on Hepatitis C Virus Envelope P...

April 2021 30 pages

Hepatitis E (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hepatitis E (Infectious Disease) - Drugs in Development, 2021 SUMMARY Hepatitis E (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Hepatitis E pipeline landscape. The repo...

April 2021 35 pages

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Hepatoc...

April 2021 130 pages

Herpesviridae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Herpesviridae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Herpesviridae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Herpesviridae...

April 2021 40 pages

Herpetic Keratitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Herpetic Keratitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Herpetic Keratitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Herpetic Keratitis pipeline landscap...

April 2021 35 pages

High-Grade Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

High-Grade Glioma (Oncology) - Drugs in Development, 2021 SUMMARY High-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the High-Grade Glioma pipeline landscape. The report...

April 2021 130 pages

Histamine H1 Receptor (HRH1) - Drugs in Development, 2021

US$ 3,000.00

Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 SUMMARY Histamine H1 Receptor (HRH1) - Drugs in Development, 2021 provides in depth analysis on Histamine H1 Receptor (HRH1) targeted pipeline...

April 2021 80 pages

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021

US$ 3,000.00

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021 SUMMARY Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Developm...

April 2021 40 pages

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) - Drugs in Development, 2021

US$ 3,000.00

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) - Drugs in Development, 2021 SUMMARY Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3...

April 2021 45 pages

Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 2021

US$ 3,000.00

Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 2021 SUMMARY Histone Deacetylase (HDAC or EC 3.5.1.98) - Drugs in Development, 2021 provides in depth analysis on Histone Deacetylase...

April 2021 140 pages

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) - Drugs in Development, 2021

US$ 3,000.00

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) - Drugs in Development, 2021 SUMMARY Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Z...

April 2021 30 pages

HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021

US$ 3,000.00

HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 SUMMARY HIV 1 Integrase (EC 2.7.7.) - Drugs in Development, 2021 provides in depth analysis on HIV 1 Integrase (EC 2.7.7.) targeted pipeline th...

April 2021 45 pages

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) - Drugs in Development, 2021

US$ 3,000.00

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) - Drugs in Development, 2021 SUMMARY HIV 1 Retropepsin (HIV Aspa...

April 2021 45 pages

HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 SUMMARY HIV Related Neurological Diseases (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 30 pages

Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Homozygous Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) - Drugs in Development,...

April 2021 50 pages

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...

April 2021 200 pages

Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone Sensitive Br...

April 2021 35 pages

Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Hormone-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone-Sensitiv...

April 2021 55 pages

Hospital-Acquired Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hospital-Acquired Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Hospital-Acquired Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Hospit...

April 2021 40 pages

HSV-1 (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

HSV-1 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-1 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-1 pipeline landscape. The report provides compre...

April 2021 30 pages

HSV-2 (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

HSV-2 (Infectious Disease) - Drugs in Development, 2021 SUMMARY HSV-2 (Infectious Disease) - Drugs in Development, 2021 provides an overview of the HSV-2 pipeline landscape. The report provides compre...

April 2021 35 pages

Human Cytomegalovirus Glycoprotein H (gH) - Drugs in Development, 2021

US$ 3,000.00

Human Cytomegalovirus Glycoprotein H (gH) - Drugs in Development, 2021 SUMMARY Human Cytomegalovirus Glycoprotein H (gH) - Drugs in Development, 2021 provides in depth analysis on Human Cytomegaloviru...

April 2021 30 pages

Human Metapneumovirus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Human Metapneumovirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Human Metapneumovirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 40 pages

Human Papillomavirus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Human Papillomavirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Human Papillomavirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the...

April 2021 115 pages

Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021

US$ 3,000.00

Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021 SUMMARY Human Papillomavirus Protein E6 (E6) - Drugs in Development, 2021 provides in depth analysis on Human Papillomavirus Protein E...

April 2021 75 pages

Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021

US$ 3,000.00

Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 SUMMARY Human Papillomavirus Protein E7 (E7) - Drugs in Development, 2021 provides in depth analysis on Human Papillomavirus Protein E...

April 2021 90 pages

Human Parainfluenza Virus 3 Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Human Parainfluenza Virus 3 Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Human Parainfluenza Virus 3 Infections (Infectious Disease) - Drugs in Development, 2021 provides an ov...

April 2021 30 pages

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) - Drugs in Development, 2021

US$ 3,000.00

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) - Drugs in Development, 2021 SUMMARY Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) - Drugs in...

April 2021 30 pages

Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021

US$ 3,500.00

Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021 SUMMARY Human SARS Coronavirus 2 Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Deve...

April 2021 325 pages

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021

US$ 3,000.00

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Development, 2021 SUMMARY Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) - Drugs in Developm...

April 2021 35 pages

Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Hutchinson...

April 2021 30 pages

Hyperargininemia (Arginase I Deficiency) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperargininemia (Arginase I Deficiency) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Hyperargininemia (Arginase I Deficiency) (Genetic Disorders) - Drugs in Development, 2021 provides an...

April 2021 30 pages

Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Hyperlipidemia (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Hyperlipidemia pipeline landscap...

April 2021 120 pages

Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 2021 SUMMARY Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 2021 provides an overview of the Hyperphosphatemia pipe...

April 2021 30 pages

Hypersomnia (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Hypersomnia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Hypersomnia (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Hypersomnia pipeline landscape....

April 2021 35 pages

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 SUMMARY Hypertriglyceridemia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Hypertriglyceridemia pipeline...

April 2021 70 pages

Hypertrophic Scars (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Hypertrophic Scars (Dermatology) - Drugs in Development, 2021 SUMMARY Hypertrophic Scars (Dermatology) - Drugs in Development, 2021 provides an overview of the Hypertrophic Scars pipeline landscape. T...

April 2021 35 pages

Filters

Clear all